Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMC Bioinformatics|May 1, 2020
Predicting potential adverse events using safety data from marketed drugsChathuri Daluwatte, Peter Schotland, David G Strauss, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 12, 2016
Improving drug safety with a systems pharmacology approachPeter Schotland, Niels Bojunga, Alexander Zien, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2018
Target-Adverse Event Profiles to Augment Pharmacovigilance: A Pilot Study With Six New Molecular EntitiesPeter Schotland, Rebecca Racz, David Jackson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 29, 2003
Novel insights into the regulation of the timeless proteinLesley J Ashmore, Sriram Sathyanarayanan, David W Silvestre, et al.
Clinical Pharmacology and Therapeutics|October 22, 2020
Target Adverse Event Profiles for Predictive Safety in the Postmarket SettingPeter Schotland, Rebecca Racz, David B Jackson, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 16, 2002
Restoration of circadian behavioural rhythms in a period null Drosophila mutant (per01) by mammalian period homologues mPer1 and mPer2Yasufumi Shigeyoshi, Elizabeth Meyer-Bernstein, Kazuhiro Yagita, et al.
The Oncologist|May 11, 2021
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with SorafenibMay Tun Saung, Lorraine Pelosof, Sandra Casak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung CancerMichael I Barbato, Diana Bradford, Yi Ren, et al.
Pageof 1